nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxazosin—ORM1—vertebral column—malignant glioma	0.0246	0.158	CbGeAlD
Doxazosin—Tonic-clonic seizures—Carmustine—malignant glioma	0.0215	0.0321	CcSEcCtD
Doxazosin—Paresis—Temozolomide—malignant glioma	0.0153	0.0229	CcSEcCtD
Doxazosin—Grand mal convulsion—Carmustine—malignant glioma	0.0122	0.0181	CcSEcCtD
Doxazosin—Faecal incontinence—Carmustine—malignant glioma	0.0115	0.0171	CcSEcCtD
Doxazosin—Faecal incontinence—Temozolomide—malignant glioma	0.0111	0.0165	CcSEcCtD
Doxazosin—KCNH6—telencephalon—malignant glioma	0.0107	0.0688	CbGeAlD
Doxazosin—Cerebration impaired—Temozolomide—malignant glioma	0.00951	0.0142	CcSEcCtD
Doxazosin—Encephalopathy—Carmustine—malignant glioma	0.00902	0.0135	CcSEcCtD
Doxazosin—Tooth disorder—Temozolomide—malignant glioma	0.00863	0.0129	CcSEcCtD
Doxazosin—Parosmia—Temozolomide—malignant glioma	0.00863	0.0129	CcSEcCtD
Doxazosin—Hypokinesia—Carmustine—malignant glioma	0.00858	0.0128	CcSEcCtD
Doxazosin—KCNH7—central nervous system—malignant glioma	0.00855	0.0549	CbGeAlD
Doxazosin—KCNH7—cerebellum—malignant glioma	0.00836	0.0537	CbGeAlD
Doxazosin—Apathy—Temozolomide—malignant glioma	0.00783	0.0117	CcSEcCtD
Doxazosin—Influenza-like symptoms—Temozolomide—malignant glioma	0.00783	0.0117	CcSEcCtD
Doxazosin—Flat affect—Temozolomide—malignant glioma	0.00776	0.0116	CcSEcCtD
Doxazosin—Scotoma—Carmustine—malignant glioma	0.00762	0.0114	CcSEcCtD
Doxazosin—Herpes zoster—Temozolomide—malignant glioma	0.00743	0.0111	CcSEcCtD
Doxazosin—Cholestasis—Temozolomide—malignant glioma	0.00737	0.011	CcSEcCtD
Doxazosin—Scotoma—Temozolomide—malignant glioma	0.00737	0.011	CcSEcCtD
Doxazosin—Otitis media—Temozolomide—malignant glioma	0.00719	0.0107	CcSEcCtD
Doxazosin—Rigors—Temozolomide—malignant glioma	0.00685	0.0102	CcSEcCtD
Doxazosin—KCNH7—brain—malignant glioma	0.00679	0.0436	CbGeAlD
Doxazosin—Speech disorder—Carmustine—malignant glioma	0.00673	0.01	CcSEcCtD
Doxazosin—Speech disorder—Temozolomide—malignant glioma	0.0065	0.00971	CcSEcCtD
Doxazosin—Disturbance in attention—Temozolomide—malignant glioma	0.00646	0.00964	CcSEcCtD
Doxazosin—Breast pain—Temozolomide—malignant glioma	0.00641	0.00957	CcSEcCtD
Doxazosin—Thinking abnormal—Carmustine—malignant glioma	0.00632	0.00944	CcSEcCtD
Doxazosin—Viral infection—Temozolomide—malignant glioma	0.00619	0.00924	CcSEcCtD
Doxazosin—KCNH6—central nervous system—malignant glioma	0.00609	0.0391	CbGeAlD
Doxazosin—Herpes simplex—Temozolomide—malignant glioma	0.00607	0.00906	CcSEcCtD
Doxazosin—ADRA1D—telencephalon—malignant glioma	0.00594	0.0381	CbGeAlD
Doxazosin—Urinary incontinence—Carmustine—malignant glioma	0.00559	0.00834	CcSEcCtD
Doxazosin—Influenza like illness—Temozolomide—malignant glioma	0.00543	0.00811	CcSEcCtD
Doxazosin—Urinary incontinence—Temozolomide—malignant glioma	0.0054	0.00806	CcSEcCtD
Doxazosin—Gynaecomastia—Carmustine—malignant glioma	0.00518	0.00773	CcSEcCtD
Doxazosin—Abnormal vision—Carmustine—malignant glioma	0.00505	0.00753	CcSEcCtD
Doxazosin—Sepsis—Carmustine—malignant glioma	0.00502	0.0075	CcSEcCtD
Doxazosin—Mental disability—Carmustine—malignant glioma	0.00502	0.0075	CcSEcCtD
Doxazosin—Abnormal vision—Temozolomide—malignant glioma	0.00488	0.00728	CcSEcCtD
Doxazosin—Mental disability—Temozolomide—malignant glioma	0.00486	0.00724	CcSEcCtD
Doxazosin—KCNH6—brain—malignant glioma	0.00484	0.0311	CbGeAlD
Doxazosin—Ear pain—Temozolomide—malignant glioma	0.00476	0.0071	CcSEcCtD
Doxazosin—Eye pain—Carmustine—malignant glioma	0.00466	0.00695	CcSEcCtD
Doxazosin—Gastroenteritis—Temozolomide—malignant glioma	0.00458	0.00684	CcSEcCtD
Doxazosin—Vascular purpura—Temozolomide—malignant glioma	0.00454	0.00677	CcSEcCtD
Doxazosin—Deafness—Temozolomide—malignant glioma	0.00454	0.00677	CcSEcCtD
Doxazosin—Eye pain—Temozolomide—malignant glioma	0.0045	0.00671	CcSEcCtD
Doxazosin—Amnesia—Carmustine—malignant glioma	0.00447	0.00667	CcSEcCtD
Doxazosin—Hot flush—Temozolomide—malignant glioma	0.00434	0.00648	CcSEcCtD
Doxazosin—Amnesia—Temozolomide—malignant glioma	0.00432	0.00645	CcSEcCtD
Doxazosin—Menopausal symptoms—Temozolomide—malignant glioma	0.0043	0.00642	CcSEcCtD
Doxazosin—Thirst—Temozolomide—malignant glioma	0.00427	0.00637	CcSEcCtD
Doxazosin—Purpura—Temozolomide—malignant glioma	0.00421	0.00629	CcSEcCtD
Doxazosin—Diplopia—Carmustine—malignant glioma	0.0042	0.00627	CcSEcCtD
Doxazosin—Gastrointestinal haemorrhage—Carmustine—malignant glioma	0.0042	0.00627	CcSEcCtD
Doxazosin—Diplopia—Temozolomide—malignant glioma	0.00406	0.00606	CcSEcCtD
Doxazosin—Face oedema—Carmustine—malignant glioma	0.00406	0.00605	CcSEcCtD
Doxazosin—Affect lability—Temozolomide—malignant glioma	0.004	0.00597	CcSEcCtD
Doxazosin—Ataxia—Carmustine—malignant glioma	0.00395	0.0059	CcSEcCtD
Doxazosin—Face oedema—Temozolomide—malignant glioma	0.00392	0.00585	CcSEcCtD
Doxazosin—Liver function test abnormal—Carmustine—malignant glioma	0.00388	0.00579	CcSEcCtD
Doxazosin—Mood swings—Temozolomide—malignant glioma	0.00385	0.00574	CcSEcCtD
Doxazosin—ADRA1A—brainstem—malignant glioma	0.00384	0.0247	CbGeAlD
Doxazosin—Hypokalaemia—Carmustine—malignant glioma	0.00382	0.00571	CcSEcCtD
Doxazosin—Ataxia—Temozolomide—malignant glioma	0.00382	0.0057	CcSEcCtD
Doxazosin—Dehydration—Temozolomide—malignant glioma	0.00378	0.00564	CcSEcCtD
Doxazosin—Dry skin—Temozolomide—malignant glioma	0.00372	0.00555	CcSEcCtD
Doxazosin—Muscular weakness—Carmustine—malignant glioma	0.00371	0.00553	CcSEcCtD
Doxazosin—Hypokalaemia—Temozolomide—malignant glioma	0.0037	0.00552	CcSEcCtD
Doxazosin—Muscular weakness—Temozolomide—malignant glioma	0.00358	0.00535	CcSEcCtD
Doxazosin—Abdominal distension—Temozolomide—malignant glioma	0.00353	0.00527	CcSEcCtD
Doxazosin—ADRA1B—central nervous system—malignant glioma	0.00345	0.0222	CbGeAlD
Doxazosin—ORM1—spinal cord—malignant glioma	0.00343	0.022	CbGeAlD
Doxazosin—Sweating increased—Temozolomide—malignant glioma	0.00342	0.0051	CcSEcCtD
Doxazosin—ADRA1A—telencephalon—malignant glioma	0.00341	0.0219	CbGeAlD
Doxazosin—Neutropenia—Carmustine—malignant glioma	0.0034	0.00507	CcSEcCtD
Doxazosin—Bronchitis—Temozolomide—malignant glioma	0.00338	0.00504	CcSEcCtD
Doxazosin—ADRA1D—central nervous system—malignant glioma	0.00337	0.0217	CbGeAlD
Doxazosin—KCNH2—telencephalon—malignant glioma	0.00329	0.0212	CbGeAlD
Doxazosin—Neutropenia—Temozolomide—malignant glioma	0.00328	0.0049	CcSEcCtD
Doxazosin—Dysuria—Temozolomide—malignant glioma	0.00328	0.0049	CcSEcCtD
Doxazosin—Hyperglycaemia—Carmustine—malignant glioma	0.00328	0.00489	CcSEcCtD
Doxazosin—Upper respiratory tract infection—Temozolomide—malignant glioma	0.00326	0.00487	CcSEcCtD
Doxazosin—Pneumonia—Carmustine—malignant glioma	0.00326	0.00486	CcSEcCtD
Doxazosin—Pollakiuria—Temozolomide—malignant glioma	0.00324	0.00484	CcSEcCtD
Doxazosin—Erectile dysfunction—Temozolomide—malignant glioma	0.00323	0.00482	CcSEcCtD
Doxazosin—Depression—Carmustine—malignant glioma	0.00323	0.00482	CcSEcCtD
Doxazosin—Photosensitivity reaction—Temozolomide—malignant glioma	0.0032	0.00478	CcSEcCtD
Doxazosin—Weight increased—Temozolomide—malignant glioma	0.00319	0.00477	CcSEcCtD
Doxazosin—Weight decreased—Temozolomide—malignant glioma	0.00318	0.00474	CcSEcCtD
Doxazosin—Hyperglycaemia—Temozolomide—malignant glioma	0.00317	0.00472	CcSEcCtD
Doxazosin—Urinary tract infection—Carmustine—malignant glioma	0.00315	0.0047	CcSEcCtD
Doxazosin—Pneumonia—Temozolomide—malignant glioma	0.00315	0.0047	CcSEcCtD
Doxazosin—Depression—Temozolomide—malignant glioma	0.00312	0.00466	CcSEcCtD
Doxazosin—Urinary tract infection—Temozolomide—malignant glioma	0.00304	0.00454	CcSEcCtD
Doxazosin—ABCB1—blood vessel—malignant glioma	0.00298	0.0191	CbGeAlD
Doxazosin—Sinusitis—Temozolomide—malignant glioma	0.00294	0.00438	CcSEcCtD
Doxazosin—Hypoaesthesia—Carmustine—malignant glioma	0.00289	0.00432	CcSEcCtD
Doxazosin—Hepatitis—Temozolomide—malignant glioma	0.00281	0.00419	CcSEcCtD
Doxazosin—Visual impairment—Carmustine—malignant glioma	0.0028	0.00418	CcSEcCtD
Doxazosin—Hypoaesthesia—Temozolomide—malignant glioma	0.0028	0.00417	CcSEcCtD
Doxazosin—Pharyngitis—Temozolomide—malignant glioma	0.00279	0.00416	CcSEcCtD
Doxazosin—ORM1—central nervous system—malignant glioma	0.00278	0.0178	CbGeAlD
Doxazosin—ADRA1B—brain—malignant glioma	0.00274	0.0176	CbGeAlD
Doxazosin—Eye disorder—Carmustine—malignant glioma	0.00272	0.00405	CcSEcCtD
Doxazosin—Visual impairment—Temozolomide—malignant glioma	0.00271	0.00404	CcSEcCtD
Doxazosin—Flushing—Carmustine—malignant glioma	0.0027	0.00403	CcSEcCtD
Doxazosin—ADRA1D—brain—malignant glioma	0.00268	0.0172	CbGeAlD
Doxazosin—Eye disorder—Temozolomide—malignant glioma	0.00263	0.00392	CcSEcCtD
Doxazosin—Tinnitus—Temozolomide—malignant glioma	0.00262	0.00391	CcSEcCtD
Doxazosin—Flushing—Temozolomide—malignant glioma	0.00261	0.00389	CcSEcCtD
Doxazosin—Arrhythmia—Carmustine—malignant glioma	0.0026	0.00388	CcSEcCtD
Doxazosin—ADRA2A—telencephalon—malignant glioma	0.00259	0.0167	CbGeAlD
Doxazosin—KCNH2—medulla oblongata—malignant glioma	0.00259	0.0166	CbGeAlD
Doxazosin—Alopecia—Carmustine—malignant glioma	0.00257	0.00383	CcSEcCtD
Doxazosin—Mental disorder—Carmustine—malignant glioma	0.00255	0.0038	CcSEcCtD
Doxazosin—Malnutrition—Carmustine—malignant glioma	0.00253	0.00378	CcSEcCtD
Doxazosin—Chills—Temozolomide—malignant glioma	0.00252	0.00376	CcSEcCtD
Doxazosin—Alopecia—Temozolomide—malignant glioma	0.00248	0.0037	CcSEcCtD
Doxazosin—Mental disorder—Temozolomide—malignant glioma	0.00246	0.00367	CcSEcCtD
Doxazosin—Back pain—Carmustine—malignant glioma	0.00245	0.00365	CcSEcCtD
Doxazosin—Malnutrition—Temozolomide—malignant glioma	0.00245	0.00365	CcSEcCtD
Doxazosin—Dysgeusia—Temozolomide—malignant glioma	0.0024	0.00357	CcSEcCtD
Doxazosin—Vision blurred—Carmustine—malignant glioma	0.00239	0.00356	CcSEcCtD
Doxazosin—Tremor—Carmustine—malignant glioma	0.00237	0.00354	CcSEcCtD
Doxazosin—Back pain—Temozolomide—malignant glioma	0.00237	0.00353	CcSEcCtD
Doxazosin—KCNH2—midbrain—malignant glioma	0.00237	0.0152	CbGeAlD
Doxazosin—Agitation—Carmustine—malignant glioma	0.00233	0.00347	CcSEcCtD
Doxazosin—KCNH2—spinal cord—malignant glioma	0.00231	0.0148	CbGeAlD
Doxazosin—Vision blurred—Temozolomide—malignant glioma	0.0023	0.00344	CcSEcCtD
Doxazosin—Tremor—Temozolomide—malignant glioma	0.00229	0.00342	CcSEcCtD
Doxazosin—Ill-defined disorder—Temozolomide—malignant glioma	0.00227	0.00339	CcSEcCtD
Doxazosin—Leukopenia—Carmustine—malignant glioma	0.00227	0.00338	CcSEcCtD
Doxazosin—CYP2D6—brainstem—malignant glioma	0.00226	0.0145	CbGeAlD
Doxazosin—Agitation—Temozolomide—malignant glioma	0.00225	0.00335	CcSEcCtD
Doxazosin—Malaise—Temozolomide—malignant glioma	0.00221	0.00329	CcSEcCtD
Doxazosin—Vertigo—Temozolomide—malignant glioma	0.0022	0.00328	CcSEcCtD
Doxazosin—Convulsion—Carmustine—malignant glioma	0.00219	0.00327	CcSEcCtD
Doxazosin—Leukopenia—Temozolomide—malignant glioma	0.00219	0.00327	CcSEcCtD
Doxazosin—Hypertension—Carmustine—malignant glioma	0.00219	0.00326	CcSEcCtD
Doxazosin—Palpitations—Temozolomide—malignant glioma	0.00216	0.00323	CcSEcCtD
Doxazosin—Chest pain—Carmustine—malignant glioma	0.00215	0.00322	CcSEcCtD
Doxazosin—Myalgia—Carmustine—malignant glioma	0.00215	0.00322	CcSEcCtD
Doxazosin—Anxiety—Carmustine—malignant glioma	0.00215	0.0032	CcSEcCtD
Doxazosin—Cough—Temozolomide—malignant glioma	0.00213	0.00318	CcSEcCtD
Doxazosin—Convulsion—Temozolomide—malignant glioma	0.00212	0.00316	CcSEcCtD
Doxazosin—Hypertension—Temozolomide—malignant glioma	0.00211	0.00315	CcSEcCtD
Doxazosin—Confusional state—Carmustine—malignant glioma	0.00208	0.00311	CcSEcCtD
Doxazosin—Arthralgia—Temozolomide—malignant glioma	0.00208	0.00311	CcSEcCtD
Doxazosin—Myalgia—Temozolomide—malignant glioma	0.00208	0.00311	CcSEcCtD
Doxazosin—Anxiety—Temozolomide—malignant glioma	0.00208	0.0031	CcSEcCtD
Doxazosin—Oedema—Carmustine—malignant glioma	0.00207	0.00308	CcSEcCtD
Doxazosin—Discomfort—Temozolomide—malignant glioma	0.00206	0.00307	CcSEcCtD
Doxazosin—Infection—Carmustine—malignant glioma	0.00205	0.00306	CcSEcCtD
Doxazosin—ADRA2A—medulla oblongata—malignant glioma	0.00204	0.0131	CbGeAlD
Doxazosin—Dry mouth—Temozolomide—malignant glioma	0.00204	0.00304	CcSEcCtD
Doxazosin—Thrombocytopenia—Carmustine—malignant glioma	0.00202	0.00302	CcSEcCtD
Doxazosin—Tachycardia—Carmustine—malignant glioma	0.00202	0.00301	CcSEcCtD
Doxazosin—Confusional state—Temozolomide—malignant glioma	0.00201	0.003	CcSEcCtD
Doxazosin—CYP2D6—telencephalon—malignant glioma	0.00201	0.0129	CbGeAlD
Doxazosin—Oedema—Temozolomide—malignant glioma	0.002	0.00298	CcSEcCtD
Doxazosin—Infection—Temozolomide—malignant glioma	0.00198	0.00296	CcSEcCtD
Doxazosin—Anorexia—Carmustine—malignant glioma	0.00197	0.00294	CcSEcCtD
Doxazosin—Thrombocytopenia—Temozolomide—malignant glioma	0.00195	0.00292	CcSEcCtD
Doxazosin—Skin disorder—Temozolomide—malignant glioma	0.00194	0.00289	CcSEcCtD
Doxazosin—ADRA1A—central nervous system—malignant glioma	0.00194	0.0124	CbGeAlD
Doxazosin—Hypotension—Carmustine—malignant glioma	0.00193	0.00288	CcSEcCtD
Doxazosin—Hyperhidrosis—Temozolomide—malignant glioma	0.00193	0.00288	CcSEcCtD
Doxazosin—Anorexia—Temozolomide—malignant glioma	0.0019	0.00284	CcSEcCtD
Doxazosin—ADRA1A—cerebellum—malignant glioma	0.00189	0.0122	CbGeAlD
Doxazosin—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00188	0.00281	CcSEcCtD
Doxazosin—KCNH2—central nervous system—malignant glioma	0.00187	0.012	CbGeAlD
Doxazosin—Insomnia—Carmustine—malignant glioma	0.00187	0.00279	CcSEcCtD
Doxazosin—ADRA2A—midbrain—malignant glioma	0.00186	0.012	CbGeAlD
Doxazosin—Paraesthesia—Carmustine—malignant glioma	0.00185	0.00277	CcSEcCtD
Doxazosin—Dyspnoea—Carmustine—malignant glioma	0.00184	0.00275	CcSEcCtD
Doxazosin—Somnolence—Carmustine—malignant glioma	0.00184	0.00274	CcSEcCtD
Doxazosin—KCNH2—cerebellum—malignant glioma	0.00183	0.0117	CbGeAlD
Doxazosin—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00182	0.00271	CcSEcCtD
Doxazosin—ADRA2A—spinal cord—malignant glioma	0.00182	0.0117	CbGeAlD
Doxazosin—Insomnia—Temozolomide—malignant glioma	0.00181	0.00269	CcSEcCtD
Doxazosin—Decreased appetite—Carmustine—malignant glioma	0.0018	0.00268	CcSEcCtD
Doxazosin—Paraesthesia—Temozolomide—malignant glioma	0.00179	0.00267	CcSEcCtD
Doxazosin—Dyspnoea—Temozolomide—malignant glioma	0.00178	0.00266	CcSEcCtD
Doxazosin—ABCB1—embryo—malignant glioma	0.00178	0.0114	CbGeAlD
Doxazosin—Somnolence—Temozolomide—malignant glioma	0.00177	0.00265	CcSEcCtD
Doxazosin—Pain—Carmustine—malignant glioma	0.00177	0.00264	CcSEcCtD
Doxazosin—Constipation—Carmustine—malignant glioma	0.00177	0.00264	CcSEcCtD
Doxazosin—Dyspepsia—Temozolomide—malignant glioma	0.00176	0.00262	CcSEcCtD
Doxazosin—Decreased appetite—Temozolomide—malignant glioma	0.00174	0.00259	CcSEcCtD
Doxazosin—Fatigue—Temozolomide—malignant glioma	0.00172	0.00257	CcSEcCtD
Doxazosin—Constipation—Temozolomide—malignant glioma	0.00171	0.00255	CcSEcCtD
Doxazosin—Pain—Temozolomide—malignant glioma	0.00171	0.00255	CcSEcCtD
Doxazosin—Feeling abnormal—Carmustine—malignant glioma	0.0017	0.00254	CcSEcCtD
Doxazosin—Gastrointestinal pain—Carmustine—malignant glioma	0.00169	0.00252	CcSEcCtD
Doxazosin—Feeling abnormal—Temozolomide—malignant glioma	0.00164	0.00245	CcSEcCtD
Doxazosin—Body temperature increased—Carmustine—malignant glioma	0.00163	0.00244	CcSEcCtD
Doxazosin—Abdominal pain—Carmustine—malignant glioma	0.00163	0.00244	CcSEcCtD
Doxazosin—Gastrointestinal pain—Temozolomide—malignant glioma	0.00163	0.00244	CcSEcCtD
Doxazosin—Urticaria—Temozolomide—malignant glioma	0.00159	0.00237	CcSEcCtD
Doxazosin—Abdominal pain—Temozolomide—malignant glioma	0.00158	0.00235	CcSEcCtD
Doxazosin—Body temperature increased—Temozolomide—malignant glioma	0.00158	0.00235	CcSEcCtD
Doxazosin—ABCB1—retina—malignant glioma	0.00157	0.0101	CbGeAlD
Doxazosin—ADRA1A—brain—malignant glioma	0.00154	0.00988	CbGeAlD
Doxazosin—Hypersensitivity—Carmustine—malignant glioma	0.00152	0.00227	CcSEcCtD
Doxazosin—KCNH2—brain—malignant glioma	0.00149	0.00954	CbGeAlD
Doxazosin—Asthenia—Carmustine—malignant glioma	0.00148	0.00221	CcSEcCtD
Doxazosin—ADRA2A—central nervous system—malignant glioma	0.00147	0.00946	CbGeAlD
Doxazosin—Hypersensitivity—Temozolomide—malignant glioma	0.00147	0.00219	CcSEcCtD
Doxazosin—ABCB1—telencephalon—malignant glioma	0.00144	0.00928	CbGeAlD
Doxazosin—ADRA2A—cerebellum—malignant glioma	0.00144	0.00925	CbGeAlD
Doxazosin—Asthenia—Temozolomide—malignant glioma	0.00143	0.00214	CcSEcCtD
Doxazosin—Diarrhoea—Carmustine—malignant glioma	0.00141	0.00211	CcSEcCtD
Doxazosin—Pruritus—Temozolomide—malignant glioma	0.00141	0.00211	CcSEcCtD
Doxazosin—Dizziness—Carmustine—malignant glioma	0.00137	0.00204	CcSEcCtD
Doxazosin—Diarrhoea—Temozolomide—malignant glioma	0.00137	0.00204	CcSEcCtD
Doxazosin—Dizziness—Temozolomide—malignant glioma	0.00132	0.00197	CcSEcCtD
Doxazosin—Vomiting—Carmustine—malignant glioma	0.00131	0.00196	CcSEcCtD
Doxazosin—Rash—Carmustine—malignant glioma	0.0013	0.00194	CcSEcCtD
Doxazosin—Dermatitis—Carmustine—malignant glioma	0.0013	0.00194	CcSEcCtD
Doxazosin—Headache—Carmustine—malignant glioma	0.00129	0.00193	CcSEcCtD
Doxazosin—Vomiting—Temozolomide—malignant glioma	0.00127	0.00189	CcSEcCtD
Doxazosin—Rash—Temozolomide—malignant glioma	0.00126	0.00188	CcSEcCtD
Doxazosin—Dermatitis—Temozolomide—malignant glioma	0.00126	0.00188	CcSEcCtD
Doxazosin—Headache—Temozolomide—malignant glioma	0.00125	0.00187	CcSEcCtD
Doxazosin—Nausea—Carmustine—malignant glioma	0.00123	0.00183	CcSEcCtD
Doxazosin—Nausea—Temozolomide—malignant glioma	0.00119	0.00177	CcSEcCtD
Doxazosin—ADRA2A—brain—malignant glioma	0.00117	0.00751	CbGeAlD
Doxazosin—CYP2D6—central nervous system—malignant glioma	0.00114	0.00733	CbGeAlD
Doxazosin—ABCB1—medulla oblongata—malignant glioma	0.00114	0.00729	CbGeAlD
Doxazosin—CYP2D6—cerebellum—malignant glioma	0.00112	0.00717	CbGeAlD
Doxazosin—ABCB1—midbrain—malignant glioma	0.00104	0.00666	CbGeAlD
Doxazosin—ABCB1—spinal cord—malignant glioma	0.00101	0.0065	CbGeAlD
Doxazosin—CYP2D6—brain—malignant glioma	0.000906	0.00582	CbGeAlD
Doxazosin—ABCB1—central nervous system—malignant glioma	0.000821	0.00527	CbGeAlD
Doxazosin—ABCB1—cerebellum—malignant glioma	0.000803	0.00515	CbGeAlD
Doxazosin—ABCB1—brain—malignant glioma	0.000652	0.00419	CbGeAlD
Doxazosin—ADRA1A—Signaling Pathways—CDKN2B—malignant glioma	3.83e-05	0.00022	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—F2—malignant glioma	3.83e-05	0.00022	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—FN1—malignant glioma	3.83e-05	0.00022	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—BCHE—malignant glioma	3.82e-05	0.000219	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—SPP1—malignant glioma	3.8e-05	0.000218	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—CXCL8—malignant glioma	3.79e-05	0.000218	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—BAD—malignant glioma	3.78e-05	0.000217	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—SLC5A5—malignant glioma	3.77e-05	0.000217	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—KRAS—malignant glioma	3.76e-05	0.000216	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—NOTCH1—malignant glioma	3.74e-05	0.000215	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—PIK3CD—malignant glioma	3.73e-05	0.000214	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—PTK2—malignant glioma	3.72e-05	0.000214	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR downstream signaling—CXCL8—malignant glioma	3.71e-05	0.000213	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—CD80—malignant glioma	3.67e-05	0.000211	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—APC—malignant glioma	3.66e-05	0.00021	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—PIK3CG—malignant glioma	3.66e-05	0.00021	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—HES1—malignant glioma	3.66e-05	0.00021	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	3.66e-05	0.00021	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—NCOR1—malignant glioma	3.64e-05	0.000209	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	3.62e-05	0.000208	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—IL2—malignant glioma	3.62e-05	0.000208	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—EGF—malignant glioma	3.62e-05	0.000208	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—TERT—malignant glioma	3.61e-05	0.000207	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—BCHE—malignant glioma	3.6e-05	0.000207	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—PTPN11—malignant glioma	3.6e-05	0.000207	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—MMP3—malignant glioma	3.59e-05	0.000206	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—RAF1—malignant glioma	3.59e-05	0.000206	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—PIK3CB—malignant glioma	3.58e-05	0.000206	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—CDKN2B—malignant glioma	3.56e-05	0.000204	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—SLC5A5—malignant glioma	3.56e-05	0.000204	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR downstream signaling—IL2—malignant glioma	3.54e-05	0.000203	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—PDGFB—malignant glioma	3.52e-05	0.000202	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—FGFR1—malignant glioma	3.5e-05	0.000201	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—PIK3CB—malignant glioma	3.5e-05	0.000201	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—PDGFRA—malignant glioma	3.48e-05	0.0002	CbGpPWpGaD
Doxazosin—ABCB1—Transmembrane transport of small molecules—RAF1—malignant glioma	3.48e-05	0.0002	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—PTK2—malignant glioma	3.46e-05	0.000199	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—PIK3CA—malignant glioma	3.46e-05	0.000198	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—HIF1A—malignant glioma	3.45e-05	0.000198	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—CXCL8—malignant glioma	3.44e-05	0.000198	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—BRAF—malignant glioma	3.44e-05	0.000198	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—HES1—malignant glioma	3.4e-05	0.000195	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—SPP1—malignant glioma	3.38e-05	0.000194	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—NCOR1—malignant glioma	3.38e-05	0.000194	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—CXCL8—malignant glioma	3.36e-05	0.000193	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—AKT2—malignant glioma	3.35e-05	0.000192	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—TP53—malignant glioma	3.34e-05	0.000192	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—CAV1—malignant glioma	3.34e-05	0.000192	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—EGFR—malignant glioma	3.34e-05	0.000192	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—RAF1—malignant glioma	3.33e-05	0.000191	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—KDR—malignant glioma	3.3e-05	0.000189	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—CAV1—malignant glioma	3.29e-05	0.000189	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—IL2—malignant glioma	3.29e-05	0.000189	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—PIK3CB—malignant glioma	3.25e-05	0.000187	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—PDGFRA—malignant glioma	3.23e-05	0.000186	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—PIK3CD—malignant glioma	3.22e-05	0.000185	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—IL2—malignant glioma	3.22e-05	0.000185	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—TERT—malignant glioma	3.2e-05	0.000184	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR downstream signaling—PIK3CA—malignant glioma	3.19e-05	0.000183	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—FN1—malignant glioma	3.18e-05	0.000182	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—F2—malignant glioma	3.18e-05	0.000182	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	3.16e-05	0.000181	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—KRAS—malignant glioma	3.15e-05	0.000181	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—SPP1—malignant glioma	3.14e-05	0.00018	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—BAD—malignant glioma	3.14e-05	0.00018	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—PDGFB—malignant glioma	3.13e-05	0.00018	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—CXCL8—malignant glioma	3.13e-05	0.00018	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—GSTP1—malignant glioma	3.11e-05	0.000179	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—FGFR1—malignant glioma	3.11e-05	0.000179	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—NOTCH1—malignant glioma	3.11e-05	0.000178	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—FGF2—malignant glioma	3.08e-05	0.000177	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—HIF1A—malignant glioma	3.06e-05	0.000176	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—CD80—malignant glioma	3.04e-05	0.000175	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—GSTP1—malignant glioma	3.04e-05	0.000175	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—APC—malignant glioma	3.04e-05	0.000175	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—PIK3CG—malignant glioma	3.04e-05	0.000175	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—CAT—malignant glioma	3.03e-05	0.000174	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—EGF—malignant glioma	3e-05	0.000172	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—PIK3CG—malignant glioma	3e-05	0.000172	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—IL2—malignant glioma	2.99e-05	0.000172	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—PTPN11—malignant glioma	2.99e-05	0.000171	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—TERT—malignant glioma	2.98e-05	0.000171	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—CAV1—malignant glioma	2.96e-05	0.00017	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—CAT—malignant glioma	2.96e-05	0.00017	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—KDR—malignant glioma	2.93e-05	0.000168	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—PDGFB—malignant glioma	2.91e-05	0.000167	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—PIK3CA—malignant glioma	2.9e-05	0.000166	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—PPARG—malignant glioma	2.89e-05	0.000166	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—FGFR1—malignant glioma	2.89e-05	0.000166	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—MDM2—malignant glioma	2.88e-05	0.000166	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—RAF1—malignant glioma	2.87e-05	0.000165	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—GSTP1—malignant glioma	2.86e-05	0.000164	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—NCOR1—malignant glioma	2.86e-05	0.000164	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—BRAF—malignant glioma	2.86e-05	0.000164	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—HIF1A—malignant glioma	2.85e-05	0.000163	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—ERBB2—malignant glioma	2.84e-05	0.000163	CbGpPWpGaD
Doxazosin—ADRA2A—Hemostasis—AKT1—malignant glioma	2.82e-05	0.000162	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—F2—malignant glioma	2.82e-05	0.000162	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—FN1—malignant glioma	2.82e-05	0.000162	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—PIK3CB—malignant glioma	2.81e-05	0.000161	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—NCOR1—malignant glioma	2.79e-05	0.00016	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—CAT—malignant glioma	2.79e-05	0.00016	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—BAD—malignant glioma	2.79e-05	0.00016	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—AKT2—malignant glioma	2.78e-05	0.00016	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—EGFR—malignant glioma	2.77e-05	0.000159	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—NOTCH1—malignant glioma	2.76e-05	0.000159	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—CAV1—malignant glioma	2.75e-05	0.000158	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—KDR—malignant glioma	2.72e-05	0.000156	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—CD80—malignant glioma	2.7e-05	0.000155	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—APC—malignant glioma	2.7e-05	0.000155	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—PIK3CG—malignant glioma	2.7e-05	0.000155	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—CXCL8—malignant glioma	2.7e-05	0.000155	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—PIK3CD—malignant glioma	2.67e-05	0.000153	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—EGF—malignant glioma	2.67e-05	0.000153	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—PTPN11—malignant glioma	2.65e-05	0.000152	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR downstream signaling—PIK3CA—malignant glioma	2.65e-05	0.000152	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—PIK3CD—malignant glioma	2.64e-05	0.000151	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—NCOR1—malignant glioma	2.63e-05	0.000151	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—FN1—malignant glioma	2.62e-05	0.00015	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—F2—malignant glioma	2.62e-05	0.00015	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—KRAS—malignant glioma	2.62e-05	0.00015	CbGpPWpGaD
Doxazosin—ADRA1D—GPCR downstream signaling—AKT1—malignant glioma	2.6e-05	0.00015	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—BAD—malignant glioma	2.59e-05	0.000149	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—CASP3—malignant glioma	2.58e-05	0.000148	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—IL2—malignant glioma	2.58e-05	0.000148	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—NOTCH1—malignant glioma	2.56e-05	0.000147	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—FGF2—malignant glioma	2.56e-05	0.000147	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—BRAF—malignant glioma	2.54e-05	0.000146	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—CD80—malignant glioma	2.51e-05	0.000144	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—PIK3CG—malignant glioma	2.51e-05	0.000144	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—APC—malignant glioma	2.51e-05	0.000144	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—EGF—malignant glioma	2.48e-05	0.000142	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—AKT2—malignant glioma	2.47e-05	0.000142	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—PTPN11—malignant glioma	2.46e-05	0.000141	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—EGFR—malignant glioma	2.46e-05	0.000141	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—MMP9—malignant glioma	2.44e-05	0.00014	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—PTEN—malignant glioma	2.42e-05	0.000139	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—PIK3CA—malignant glioma	2.4e-05	0.000138	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—MDM2—malignant glioma	2.39e-05	0.000137	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—RAF1—malignant glioma	2.39e-05	0.000137	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—PIK3CD—malignant glioma	2.37e-05	0.000136	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling by GPCR—AKT1—malignant glioma	2.37e-05	0.000136	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—ERBB2—malignant glioma	2.36e-05	0.000136	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—BRAF—malignant glioma	2.36e-05	0.000135	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR downstream signaling—PIK3CA—malignant glioma	2.35e-05	0.000135	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—CAV1—malignant glioma	2.33e-05	0.000134	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—PIK3CB—malignant glioma	2.33e-05	0.000134	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—KRAS—malignant glioma	2.32e-05	0.000133	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—PIK3CB—malignant glioma	2.3e-05	0.000132	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—AKT2—malignant glioma	2.29e-05	0.000132	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—EGFR—malignant glioma	2.29e-05	0.000131	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—PTGS2—malignant glioma	2.28e-05	0.000131	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—CAV1—malignant glioma	2.28e-05	0.000131	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—FGF2—malignant glioma	2.27e-05	0.00013	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—CXCL8—malignant glioma	2.24e-05	0.000129	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	2.23e-05	0.000128	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—PIK3CD—malignant glioma	2.2e-05	0.000127	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—VEGFA—malignant glioma	2.19e-05	0.000126	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—PIK3CA—malignant glioma	2.18e-05	0.000125	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—STAT3—malignant glioma	2.17e-05	0.000125	CbGpPWpGaD
Doxazosin—ADRA1B—GPCR downstream signaling—AKT1—malignant glioma	2.16e-05	0.000124	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—KRAS—malignant glioma	2.16e-05	0.000124	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—CAV1—malignant glioma	2.15e-05	0.000123	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—CASP3—malignant glioma	2.14e-05	0.000123	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—IL2—malignant glioma	2.14e-05	0.000123	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—PIK3CA—malignant glioma	2.13e-05	0.000123	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—MDM2—malignant glioma	2.13e-05	0.000122	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—PIK3CG—malignant glioma	2.13e-05	0.000122	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—RAF1—malignant glioma	2.12e-05	0.000122	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—FGF2—malignant glioma	2.11e-05	0.000121	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—ERBB2—malignant glioma	2.1e-05	0.00012	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—PIK3CG—malignant glioma	2.07e-05	0.000119	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—PIK3CB—malignant glioma	2.07e-05	0.000119	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—PPARG—malignant glioma	2.05e-05	0.000118	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—MMP9—malignant glioma	2.02e-05	0.000116	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—MYC—malignant glioma	2.01e-05	0.000116	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—PTEN—malignant glioma	2.01e-05	0.000116	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—PPARG—malignant glioma	2e-05	0.000115	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—CXCL8—malignant glioma	1.99e-05	0.000114	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—PTEN—malignant glioma	1.99e-05	0.000114	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—PIK3CA—malignant glioma	1.98e-05	0.000114	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—MDM2—malignant glioma	1.98e-05	0.000113	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—EGFR—malignant glioma	1.97e-05	0.000113	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—RAF1—malignant glioma	1.97e-05	0.000113	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling by GPCR—AKT1—malignant glioma	1.96e-05	0.000113	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—PIK3CG—malignant glioma	1.95e-05	0.000112	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—ERBB2—malignant glioma	1.95e-05	0.000112	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—PIK3CB—malignant glioma	1.92e-05	0.00011	CbGpPWpGaD
Doxazosin—ADRA1A—GPCR downstream signaling—AKT1—malignant glioma	1.92e-05	0.00011	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—CASP3—malignant glioma	1.9e-05	0.000109	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—IL2—malignant glioma	1.9e-05	0.000109	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—PPARG—malignant glioma	1.89e-05	0.000108	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—PIK3CD—malignant glioma	1.87e-05	0.000107	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—KRAS—malignant glioma	1.86e-05	0.000107	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—CXCL8—malignant glioma	1.85e-05	0.000106	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—PIK3CD—malignant glioma	1.82e-05	0.000105	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—VEGFA—malignant glioma	1.82e-05	0.000104	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—STAT3—malignant glioma	1.8e-05	0.000103	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—MMP9—malignant glioma	1.8e-05	0.000103	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—PTEN—malignant glioma	1.79e-05	0.000103	CbGpPWpGaD
Doxazosin—ADRA2A—GPCR downstream signaling—AKT1—malignant glioma	1.78e-05	0.000102	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—CASP3—malignant glioma	1.77e-05	0.000102	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—IL2—malignant glioma	1.76e-05	0.000101	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling by GPCR—AKT1—malignant glioma	1.74e-05	0.0001	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—PIK3CD—malignant glioma	1.72e-05	9.87e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—PIK3CA—malignant glioma	1.71e-05	9.82e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—MYC—malignant glioma	1.67e-05	9.6e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—MMP9—malignant glioma	1.67e-05	9.59e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—PTEN—malignant glioma	1.66e-05	9.54e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—TP53—malignant glioma	1.65e-05	9.5e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—EGFR—malignant glioma	1.64e-05	9.39e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—PIK3CB—malignant glioma	1.63e-05	9.35e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling by GPCR—AKT1—malignant glioma	1.62e-05	9.3e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—VEGFA—malignant glioma	1.61e-05	9.27e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—PTGS2—malignant glioma	1.61e-05	9.26e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—STAT3—malignant glioma	1.6e-05	9.18e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—PIK3CB—malignant glioma	1.59e-05	9.13e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—PTGS2—malignant glioma	1.57e-05	9.04e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—KRAS—malignant glioma	1.55e-05	8.87e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—VEGFA—malignant glioma	1.5e-05	8.61e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—PIK3CB—malignant glioma	1.5e-05	8.6e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—MYC—malignant glioma	1.49e-05	8.53e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—STAT3—malignant glioma	1.49e-05	8.53e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—PTGS2—malignant glioma	1.48e-05	8.52e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—EGFR—malignant glioma	1.45e-05	8.34e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—PIK3CA—malignant glioma	1.42e-05	8.15e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—PTEN—malignant glioma	1.41e-05	8.08e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—PIK3CA—malignant glioma	1.4e-05	8.05e-05	CbGpPWpGaD
Doxazosin—ADRA1D—Signaling Pathways—AKT1—malignant glioma	1.4e-05	8.02e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—MYC—malignant glioma	1.38e-05	7.92e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—PTEN—malignant glioma	1.37e-05	7.89e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—TP53—malignant glioma	1.37e-05	7.89e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—KRAS—malignant glioma	1.37e-05	7.88e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—EGFR—malignant glioma	1.35e-05	7.75e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—PTEN—malignant glioma	1.29e-05	7.43e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—KRAS—malignant glioma	1.28e-05	7.32e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—PIK3CA—malignant glioma	1.26e-05	7.24e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—TP53—malignant glioma	1.22e-05	7e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—PIK3CA—malignant glioma	1.17e-05	6.73e-05	CbGpPWpGaD
Doxazosin—ADRA1B—Signaling Pathways—AKT1—malignant glioma	1.16e-05	6.66e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Metabolism—AKT1—malignant glioma	1.14e-05	6.57e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—TP53—malignant glioma	1.13e-05	6.51e-05	CbGpPWpGaD
Doxazosin—ADRA1A—Signaling Pathways—AKT1—malignant glioma	1.03e-05	5.91e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—PIK3CA—malignant glioma	9.93e-06	5.7e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—PIK3CA—malignant glioma	9.69e-06	5.56e-05	CbGpPWpGaD
Doxazosin—ADRA2A—Signaling Pathways—AKT1—malignant glioma	9.57e-06	5.5e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—PIK3CA—malignant glioma	9.13e-06	5.24e-05	CbGpPWpGaD
Doxazosin—CYP2C19—Metabolism—AKT1—malignant glioma	8.11e-06	4.66e-05	CbGpPWpGaD
Doxazosin—ABCB1—Metabolism—AKT1—malignant glioma	7.91e-06	4.54e-05	CbGpPWpGaD
Doxazosin—CYP2D6—Metabolism—AKT1—malignant glioma	7.46e-06	4.28e-05	CbGpPWpGaD
